Search Results - "Kuriyama, Steve"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    1490. Vancomycin 125 mg vs. 250 mg for the Treatment of Non-Severe and Severe Clostridium difficile Infections

    1490. Vancomycin 125 mg vs. 250 mg for the Treatment of Non-Severe and Severe Clostridium difficile Infections by Hsu, Amy, Richardson, Caitlin, Kuriyama, Steve M

    Published in Open forum infectious diseases (23-10-2019)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Under the Radar: Balamuthia Amebic Encephalitis

    Under the Radar: Balamuthia Amebic Encephalitis by Schuster, Frederick L., Yagi, Shigeo, Gavali, Shilpa, Michelson, David, Raghavan, Ravi, Blomquist, Ingrid, Glastonbury, Christine, Bollen, Andrew W., Scharnhorst, David, Reed, Sharon L., Kuriyama, Steve, Visvesvara, Govinda S., Glaser, Carol A.

    Published in Clinical infectious diseases (01-04-2009)
    “…Background. We present data from 9 years (1999–2008) of tests for Balamuthia mandrillaris, an agent of amebic encephalitis that were conducted as part of the…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Phagolysosome Formation by Polymorphonuclear Neutrophilic Leukocytes After Ingestion of Escherichia coli that Express Type 1 Pili

    Phagolysosome Formation by Polymorphonuclear Neutrophilic Leukocytes After Ingestion of Escherichia coli that Express Type 1 Pili by Goetz, Matthew Bidwell, Kuriyama, Steve M., Silverblatt, Fredric J.

    Published in The Journal of infectious diseases (01-07-1987)
    “…Escherichia coli that express type 1 pili T1P super(+) E. coli) adhere to human polymorphonuclear neutrophilic leukocytes (PMNLs) and are subsequently ingested…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: